BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Anticancer prodrugs
,
Rapamycin
,
rs2300478
,
TGFB1
,
nitric oxide metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
sulfonylurea receptor activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Heart
Uterus
Adipose tissue subcutaneous
Colon cecum
Kidney cortex
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hypoglycemia
Alpha-1-antitrypsin deficiency
Disorder of endocrine system
Multiple-resistant Staphylococcus aureus infection
Disorder of digestive system
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
clopidogrel
trimethobenzamide
rabeprazole
Nafenopin
erlotinib
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
NSDHL
BAZ1B
NDUFB8
CFH
Cyp2g1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
Spatio-temporal transcriptome of the human brain
Genomics Assisted Toxicity Evaluation system study - Rat Liver Repeat Doses
Liver gene expression profiles in response to dosing of rats with 8 different hepatotoxicants
Livers of rat exposed to variety of hepatotoxic compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhibition of ATP-sensitive K+ channel by a non-sulfonylurea compound KAD-1229 in a pancreatic beta-…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes
Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ